0001209191-15-068183.txt : 20150827
0001209191-15-068183.hdr.sgml : 20150827
20150827154612
ACCESSION NUMBER: 0001209191-15-068183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150826
FILED AS OF DATE: 20150827
DATE AS OF CHANGE: 20150827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151078734
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-26
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-08-26
4
M
0
10400
35.64
A
355684
D
Common Stock
2015-08-26
4
S
0
900
122.09
D
354784
D
Common Stock
2015-08-26
4
S
0
4082
123.09
D
350702
D
Common Stock
2015-08-26
4
S
0
600
124.44
D
350102
D
Common Stock
2015-08-26
4
S
0
2000
125.15
D
348102
D
Common Stock
2015-08-26
4
S
0
1200
126.21
D
346902
D
Common Stock
2015-08-26
4
S
0
200
126.95
D
346702
D
Common Stock
2015-08-26
4
S
0
900
128.67
D
345802
D
Common Stock
2015-08-26
4
S
0
518
129.51
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-08-26
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
229600
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $122.09 (range $121.81 to $122.71).
Open market sales reported on this line occurred at a weighted average price of $123.09 (range $122.82 to $123.71).
Open market sales reported on this line occurred at a weighted average price of $124.44 (range $123.84 to $124.75).
Open market sales reported on this line occurred at a weighted average price of $125.15 (range $124.88 to $125.76).
Open market sales reported on this line occurred at a weighted average price of $126.21 (range $125.88 to $126.66).
Open market sales reported on this line occurred at a weighted average price of $126.95 (range $126.95 to $126.95).
Open market sales reported on this line occurred at a weighted average price of $128.67 (range $128.03 to $128.93).
Open market sales reported on this line occurred at a weighted average price of $129.51 (range $129.25 to $129.85).
Fully vested.
Omar White, Attorney-In-Fact
2015-08-27